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A p.C217R Mutation in Fibulin-5 from Cutis Laxa
Patients Is Associated with Incomplete Extracellular
Matrix Formation in a Skin Equivalent Model
Stephanie Claus1,8, Judith Fischer2, Hala Me´garbane´3, Andre´ Me´garbane´4, Florence Jobard2, Romain Debret1,
Simone Peyrol5, Safa Saker6, Martine Devillers7, Pascal Sommer1 and Odile Damour1,8
Cutis laxa (CL) is a rare genodermatosis, which is clinically and genetically heterogeneous. It is characterized by
redundant, loose, sagging, and inelastic skin. In a consanguineous family from Lebanon with autosomal-
recessive transmission, we identified a homozygous missense mutation (c.649T-C; p.C217R) in the fibulin-5
gene (FBLN5), which was, to our knowledge, previously unreported. Small skin biopsies were performed, which
permitted isolation of skin fibroblasts harboring this FBLN5 mutation; they exhibited a deficit in cell growth.
A CL skin equivalent (CL-SE) model compared with control SE was successfully developed to define the
behavior of CL fibroblasts in a three-dimensional model. There was increased cell death and a global
extracellular matrix deficiency in the dermis of this CL-SE model, and a low level of the main elastic fiber
expression. There was no basement membrane evident at the ultrastructural level, and type-VII collagen could
not be detected at the histological level. This model reproduced some defects of the extracellular matrix and
highlighted other defects, which occurred at the time of the basement membrane formation, which were not
evident in skin from patients. This CL-SE model could be adapted to screen for therapeutically active molecules.
Journal of Investigative Dermatology (2008) 128, 1442–1450; doi:10.1038/sj.jid.5701211; published online 10 January 2008
INTRODUCTION
Inherited cutis laxa (CL) is a heterogeneous group of
genodermatoses that affects elastic tissues. It is characterized
by loose, flabby skin, which appears prematurely aged, with
variable internal organ involvement. Less than 100 cases
have been described to date in the literature, including
autosomal-dominant (OMIM 123700), autosomal-recessive
(OMIM 219100), and X-linked forms (OMIM 304150).
The X-linked form of CL is due to mutations in the
ATP7A gene (ATPase Cu2þ transporting, a-polypeptide
gene), which is localized at Xq12. It is now classified as a
copper deficiency syndrome and has been shown to be allelic
with Menkes disease and occipital horn syndrome. Interest-
ingly, X-linked recessive connective tissue disorders such as
Menkes disease or CL have been associated with a deficiency
in lysyl oxidase (LOX), a Cu2þ -dependent enzyme required
for elastic fiber formation (Byers et al., 1980; Kodama et al.,
2001).
The autosomal-dominant forms of CL may have their
onset at any age. Little is known about these forms and
genetic heterogeneity is probable. One of the dominant forms
is allelic to Williams–Beuren syndrome and is related
to mutations in the elastin (ELN) gene (Tassabehji et al.,
1998; Zhang et al., 1999) localized on chromosome
7q11.2. Besides skin manifestations, some patients present
with cardiovascular abnormalities such as pulmonary steno-
sis, redundant mitral, and tricuspid valves or mild dilatation
of the proximal aorta. The mutations are all localized within
the C-terminal end of elastin. A heterozygous mutation in
the FBLN5 gene has also been described in one sporadic
autosomal-dominant forms of CL patient (Markova et al.,
2003).
Autosomal-recessive CL is usually evident at birth. The less
frequent but most severe form, type I, is associated with a
generalized disorder of elastic tissue leading to pulmonary
emphysema, umbilical, inguinal, and diaphragmatic hernias,
and gastrointestinal and vesicourinary tract diverticuli. Loeys
et al. (2002) identified a homozygous causative missense
mutation in the FBLN5 gene for type-I autosomal-recessive
CL in a large Turkish family. Type II is called CL with joint
laxity and developmental delay. It is characterized by
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prenatal and postnatal growth deficiency, large fontanels
with delayed closure, congenital hip dislocation, and
lax joints. No gene localization or mutation for type II has
been reported to date. Mutations have also been described
in fibulin 4 (FBLN4) in autosomal-recessive CL patients
(Hucthagowder et al., 2006).
The recent discoveries of ELN and FBLN mutations
associated with CL pave the way for new studies about the
role of disorganized elastogenesis in cell behavior and tissue
ontogenesis. Elastin is largely responsible for the elasticity of
tissues such as blood vessels, lung, and skin, and these tissues
undergo irreversible degradative changes over time without
being efficiently replaced. Elastic fibers are composed of
multiple components and consist of elastin and fibrillin-rich
microfibrils, involving up to 19 proteins (Kielty et al., 2002).
Elastin is synthesized as a 70 kDa monomer precursor, which
is secreted through a trans-Golgi pathway. Elastogenesis is
mainly controlled by the 67 kDa elastin-binding protein,
which acts as a recycling chaperone and may bring the
tropoelastin molecule to the microfibrillar scaffold. Inter-
action of tropoelastin with fibrillin-1 and fibrillin-2 then leads
to assembly of the elastic fibers (Kozel et al., 2003; Clarke
et al., 2005). Fibulin-5 has been reported to act as a scaffold
protein at the surface of elastic fibres and microfibrils, and
to organize and link elastic fibers to cells (Nakamura et al.,
2002; Yanagisawa et al., 2002; Freeman et al., 2005).
Fibulin-5 promotes coacervation and alignment of tropo-
elastin on microfibrils and facilitates crosslinking of tropo-
elastin by tethering lysyl oxidase-like (LOXL) 1, 2, and 4
(Hirai et al., 2007). These enzymes, together with LOX, can
initiate the crosslinking reaction, which renders tropoelastin
insoluble (Vrhovski and Weiss, 1998). Two enzymes, LOX
and LOXL have been shown to be important in the elastin
crosslinking process (Borel et al., 2001; Liu et al., 2004;
Noblesse et al., 2004; Thomassin et al., 2005).
Our objective was to perform an expression study on
CL fibroblasts in a three-dimensional context. Therefore, a
CL skin equivalent (CL-SE) model was developed and used to
study the behavior of CL fibroblasts under three-dimensional
conditions, which favor the formation of functional elastic
fibers in vitro (Duplan-Perrat et al., 2000).
RESULTS
Mutation analysis was performed in a consanguineous
Lebanese CL family, which revealed a causative homozygous
missense mutation in the FBLN5 gene (Figure 1). A mutation,
which was not present in healthy control individuals from
a Mediterranean population, replaced T with C at nucleotide
position 649 (c.649T-C), leading to a p.C217R substitution
at the protein level, within a cysteine-rich domain of the
protein. Both parents were heterozygous for the mutation,
whereas the two unaffected brothers were homozygous for
the wild-type allele (wt/wt).
The two affected children displayed clear clinical features
of CL. The parents were healthy; the father was 44 years old
and the mother 32 years at the time of the first birth. How-
ever, both have short stature and the father presents some
features suggesting an early aged appearance. Patient 1 was
born as the third son after an uneventful pregnancy of
40 weeks. Birth weight was 4,000 g, and length was 51 cm.
Bilateral inguinal hernias were noted at birth and surgery was
performed at age 6 months. At 1 month of age, the parents
noticed redundant loose skin, especially evident on the face,
the abdomen, and the dorsum of the hands and feet. Early
developmental milestones were within normal limits; he
walked at 13 months and started saying a few words at
16 months. According to the mother, the anterior fontanel
was unusually wide and closed at age 3 years. He attends
a normal school.
p.C217R / wt
p.C217R / p.C217R p.C217R / p.C217R
Control
Father
Patient
wt / wt wt / wt
p.C217R / wt
Figure 1. Recessive inheritance of C217R mutation in FBLN5. (a) Pedigree
of inbred kindred with autosomal-recessive CL. Filled and open symbols
denote clinically affected and unaffected individuals, respectively. The
double horizontal line indicates consanguinity. DNA sequence analysis of
FBLN5 revealed a homozygous 649T-C (p.C217R) mutation in the two
patients; both parents were heterozygous and the two unaffected brothers
displayed a homozygous wild-type sequence (wt). (b) Sequence analysis
of FBLN5 shows a homozygous 649T-C (C217R) mutation in one patient,
one heterozygous parent and, a healthy control individual. The mutation
position is shaded and indicated by an arrow.
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Patient 2, his sister, was born 3 years after her affected
brother. Gestation and delivery at term were unremarkable.
Redundant loose skin was evident. She underwent surgery at
age 2 months and then at age 2 years for bilateral inguinal
hernias.
The boy was first examined at the age of 8 years. He had
a hoarse voice without speech distortion and an appearance
of early aging. The skin appeared prematurely aged,
lax, wrinkled, and inelastic. Bilateral ptosis, ectropion of
the external part of both lower lids with an entropion of
the internal part, large ears, drooping cheeks, small mouth,
and multiple dental caries were found. Joint flexibility,
palms and soles, and abdominal ultrasound examination
were normal. The external genitalia, and neurological and
ophthalmologic examinations were normal. Echocardio-
graphy revealed the presence of a dilated right ventricle with
good contractility without any evidence of left–right shunt.
The girl was first examined at the age of 5 years. Her facial
features were similar to those of her affected brother and she
also presented kyphoscoliosis. Echocardiography revealed
the presence of a small ostium secundum. Total-body X-rays
showed delayed bone maturation. Two months later, she was
admitted to the hospital because of severe pulmonary
emphysema, from which she recovered.
In the skin samples from these CL patients, the dermis
pattern appeared peculiar, with lacunar texture and roughly
defined fibrous components (Figure 2a–c). Orcein staining
revealed thin elastic fibers in normal human skin, which
contrasted with the absence of elastic fibers in patient
biopsies (Figure 2d–f). At the dermal–epidermal junction
(DEJ), the laminin staining appeared sharp, delineating a
lamina densa that was thinner in the biopsy from the boy
with a homozygous mutation (Figure 2g–i). However, neither
type-IV (Figure 2j–l) nor type-VII collagen (Figure 2m–o)
staining was different in CL skin compared to controls.
A CL-SE model was developed to explore the behavior of
the CL fibroblasts under three-dimensional growth condi-
tions. Fibroblasts from the male patient displaying the FBLN5
p.C217R mutation were used to construct our CL-SE model.
Foreskin fibroblasts from an unaffected individual of the
same age were used as controls to validate the procedures
used throughout the SE studies. It should be noted that in
NHS Homozygous FBLN5
male
Homozygous FBLN5
female
a b c
d e f
g h i
j k l
m n o
Figure 2. Histological and immunohistochemical analysis of skin biopsies from CL patients. The control skin was obtained from normal human foreskin
of a healthy boy (NHS) (a, d, g, j, m) Biopsies were obtained from the affected boy with CL harboring the homozygous FBLN5 mutation (b, e, h, k, n) and from
his affected sister who also displayed the homozygous FBLN5 mutation (c, f, i, l, o). Hematoxylin-phloxine-saffron staining (HPS) (a–c), and orcein staining
(d–f), immunodetection of laminin (g–i), type-IV (j–l) and type-VII (m–o) collagens. Bar¼ 25mm (a–o) and insets 5mm (g–o).
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monolayer culture, the CL fibroblasts required twice as
much time to gain confluence as control cells (data not
shown). This was consistent with their behavior in the CL-SE
model: although the CL-SE displayed the general features of
skin (Figure 3a), the CL fibroblasts proliferated poorly when
compared to control SE (Figure 3b) and they did not colonize
the substratum well; the cells died frequently, as judged by
the TUNEL assay; and the matrix tissue they synthesized was
weak and loose (Figure 3c and d). This CL-SE matrix did not
fill the foam pore surface, which led to infiltration of the
dermis by keratinocytes (Figure 3e). These infiltrations were
particularly frequent after only 2 weeks of dermis cultivation
(and 35 days of SE), but were also found after 3 weeks of
dermis cultivation (and 42 days of SE). These infiltrations
were absent or rare in control SEs (Figure 3f). However,
epidermal differentiation did occur, as suggested by the
detection of filaggrin, a keratinocyte terminal differentiation
marker, within the superior layers (data not shown).
At the ultrastructural level, the control fibroblasts formed a
well-shaped matrix, whereas in CL-SE the extracellular matrix
deposits displayed a low density and loose organization.
The collagen fibers were not well organized in bundles in the
CL-SE, as compared to controls (Figure 4a and b). In the
control SE, there was some evidence for the presence of
elastic fibers as judged by parallel arrangement of elastin-
associated microfibrils in tight bundles, with a few amor-
phous deposits (Figure 4c). On the contrary, after the same
period of culture, the CL matrix fibrillar components were
depleted, and elastin-associated microfibrils were scarce
without superimposed elastin deposition (Figure 4d).
The formation of elastic tissues was affected in the CL-SE
model but elastin was produced and detected, essentially
under the DEJ. At this level, in the CL-SE, the labeling was
condensed on small aggregates distributed homogeneously,
whereas in control SE, elastin appears as deposits below the
epidermis (Figure 5a and b). Fibulin-5 appeared to be mostly
intracellular within the CL-SE dermis (Figure 5c and d). Small
amounts of LOX were also observed (Figure 5e and f). LOXL
was not or was only weakly detected in the dermis under the
DEJ (Figure 5g and h). No clear alteration of the main skin
metalloproteases (MMP2, -7, -9) or fibrillin-1 was detected in
the CL-SE, as compared to the control SE (data not shown).
Expression at the mRNA level of several genes related to
elastic fibers appeared globally reduced in CL-SE when
compared to control SE (Figure 5i). It should be noted that
FBLN5, FBN1, and LOXL expression was particularly affected
in CL-SE. As some matrix components are also expressed
by keratinocytes, we checked the specific expression of these
genes in fibroblasts grown in monolayer cultures. Under
these conditions, FBLN5, LOXL, and ELN genes were poorly
expressed by CL cells (Figure 6a). Despite a decrease in
FBLN5 mRNA expression in CL fibroblasts, the protein was
detected in cell extracts (Figure 6b). However, the ratio
between fibulin-5 accumulation in conditioned medium after
24 hours and the protein contained in cell extracts was
weaker in CL cells than in control cells, as established by
densitometric analysis of the bands (0.52 vs 0.74, respec-
tively). Altogether, these findings reinforced the observation
of poor formation of extracellular matrix and elastic fibers in
the CL-SE model.
The formation of the basement membrane was also
affected in the CL-SE model. Type-IV collagen displayed a
more diffuse localization in the CL-SE than in controls where
its detection clearly labeled the lamina densa (Figure 7a and
b). Type-VII collagen was not observed in the CL-SE, whereas
it was apparent in the lamina densa of the control SE (Figure
7c and d). Laminin staining (Figure 7e and f), including
laminin-5 (data not shown), was associated with the base-
ment membrane and displayed the same diffuse aspect as for
type-IV collagen. These observations suggested a defect in
basement membrane formation in the CL-SE. This was further
highlighted by transmission electron microscopy where
an absence of lamina densa was evidenced at the DEJ level
of CL-SE (Figure 4f), whereas, under the same conditions of
growth, a fine and well-defined lamina densa was observed
in the control (Figure 4e).
DISCUSSION
This work confirms the implication of the FBLN5 mutation in
CL (Loeys et al., 2002; Elahi et al., 2006; Hu et al., 2006).
This is consistent with the description of a direct involvement
of fibulin-5 in the formation of microfibrils and elastic fibers
(Freeman et al., 2005; Zheng et al., 2006, 2007). Recently,
Hirai et al. (2007) have further demonstrated that deposition
0
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Figure 3. Histological analysis and TUNEL assay of CL (CL-SE) and control
skin equivalents (SE). The dermal equivalent (DE) was prepared with
fibroblasts extracted from a biopsy of the young boy with cutis laxa
(CL) harboring the FBLN5 p.C217R mutation (a, c, e) or from foreskin of
healthy boys at the same age (b, d). Non-mutated keratinocytes were seeded
on these DEs. SEs were harvested after 42 days of fibroblast culture (a–e)
and stained with hematoxylin-phloxine-saffron (a, b, e). TUNEL assay was
applied on CL-SE (c) and control SE (d), where the DEJ is represented by a
dotted line and apoptotic cells are indicated with white arrows. Keratinocyte
foci in the DE were seen and counted in all SEs (f). These foci were
mostly present in CL-SE at 35 days of culture, with only 2 weeks of dermis
cultivation (data not shown, f), but also in CL-SEs at 42 days, with 3 weeks
of dermis growth (e, black arrow). Bar¼50mm.
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of fibulin-5 on microfibrils promotes coacervation and
alignment of tropoelastin on microfibrils, and also facilitates
LOX-dependent crosslinking. The region in which we found
this yet unreported mutation, at protein position 217, might
have an important role, as a recent study has reported a Ser to
Pro substitution at position 227 of FBLN5 that affects the
formation of elastic fibers and causes a recessive CL
phenotype (Hu et al., 2006). The Cys217 residue is conserved
in fibulins-1 to -5, but not in fibulin-6, and is enclosed in the
Cys125 to Cys314 fibulin-5 segment, which is highly conserved
in fibulins. The replacement of a Cys residue at position 217
by an Arg might interfere with the formation of disulfide
bridges with other cysteines within this region. This alteration
might also interfere with the binding of LOXL, for which an
interaction has been found with the C-terminal 245–448
region of fibulin-5 (Liu et al., 2004).
The p.C217R mutation in fibulin-5 leads to a decrease in
cell growth and cell survival in the SE model and induces a
global diminution of gene expression for several components
of the elastic fibers. The previously discussed S227P mutation
in fibulin-5 also affects cell survival (Hu et al., 2006). These
effects on cell regulation might be controlled by a direct
effect of fibulin-5 on cell proliferation, motility, and invasion
(Schiemann et al., 2002). The decrease in LOX expression
should also affect the cell phenotype, as this enzyme appears
to be involved in a general but still controversial control of
cell growth and differentiation (Trackman, 2005), notably in
a b
c d
e f
Control SE CL-SE
Figure 4. Transmission electron microscopy of control SE and CL SE at
42 days. At the dermis extracellular matrix (ECM) level, collagen fibers
observed in control SE (a) appeared disorganized in CL-SE (b). Although
the microfibril network can be seen with a light amorphous deposit (black
arrows) in control SE (c), it was less present or almost absent in CL-SE (d).
At the DEJ, the basement membrane was clearly distinguishable in control
SE (e) but not in CL-SE (f) (black arrows). Bar¼0.2 mm.
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Figure 5. Immunohistochemical and real-time quantitative reverse
transcription-PCR (RT-PCR) analysis of the SE extracellular matrix (ECM).
Immunohistochemical analysis of CL-SEs (b, d, f, h) and control SEs (a, c, e, g)
after 42 days of fibroblast culture. Elastin (a, b), fibulin-5 (c, d), lysyl oxidase
(LOX) (e, f), and lysyl oxidase-like (LOXL) (g, h) immunodetection was
performed by immunoperoxidase labeling. The immunolabeling is indicated
by a brown deposition and the counterstaining gives the tissue its blue color.
The chitosan-crosslinked collagen–GAG matrix appears in blue. Bar¼ 25mm.
(i) Real-time quantitative RT-PCR analysis of FBN1, LOX, LOXL, FBLN5, and
ELN gene expression in SEs. SEs were harvested after 30 days of fibroblast
culture (2 days after exposure to air–liquid interface). Gene expression was
normalized to the expression of the reference GAPDH gene and expressed
as relative means±SEM. ELN expression was multiplied by 100.
1446 Journal of Investigative Dermatology (2008), Volume 128
S Claus et al.
Cutis Laxa Skin Equivalent
the epidermis (Bouez et al., 2006). It should also affect the
formation of the basement membrane, in which type-IV
collagen crosslinking is required. The same consideration is
true for fibrillin-1, which is expressed by dermal fibroblasts
and keratinocytes, and microfibrils are found at their interface
(Tiedemann et al., 2005). Moreover, morphogenesis of micro-
fibrils begins at the DEJ and precedes elastic fiber formation
in regenerating skin (Raghunath et al., 1996). Therefore, a
missense mutation in fibulin-5 might have direct conse-
quences on protein function and indirect consequences due
to the downregulation of other elastic fiber components.
This study describes the development of a CL-SE model
under conditions that mimic some characteristics of human
tissues such as neosynthesis. Maturation of collagen and
elastic fibers have been described in the SE model (Duplan-
Perrat et al., 2000) vs a control prepared with age-matched
cells. The limitation of our experiments is that the fibroblasts
were not site matched in the CL-SE and control SE models,
but we have previously observed great variation among cells
originating from the site-matched cells of different ages
(Lacroix et al., 2007). However, we have demonstrated that
in the CL-SE model, fibroblasts synthesized a dermal
substrate, which was poorly filled by an abnormal and loose
extracellular matrix. The collagen framework exhibited a
weak density, with less numerous collagen fibers that were
smaller than normal in diameter, which is consistent with the
lacunar aspect observed in CL patient biopsies. The elastic
network observed in CL-SE was condensed under the DEJ and
roughly structured in deep dermis where the elastic network
was atrophic. Thus, our CL-SE model demonstrated that the
mutation of a single protein influenced global ontogenesis of
elastic and collagen fibers. Another significant result was the
dysmorphism of the basal lamina. In the CL-SE, the abnormal
distribution of the basement membrane components (type-IV
and type-VII collagens, laminins) was illustrated by the
absence of lamina densa at the ultramicroscopical level.
However, as a deficit of collagen VII, a late DEJ marker
during SE formation, which may reflect the immaturity of
the matrix, has also been observed using fibroblasts from
aged donors to establish the SE (Lacroix et al., 2007), this
deficit might also reflect an ‘‘age-related’’ phenotype of the
CL fibroblasts or the influence of a slower maturation of
the dermal component.
In conclusion, we have shown the deleterious influence of
the single fibulin-5 p.C217R mutation on SE formation. This
CL-SE model highlights some expected and unexpected
defects at the DEJ level that could not be clearly detected
in native CL skin biopsies from patients or using fibroblasts
grown under two-dimensional conditions. This model might
have pharmaceutical relevance in defining new targets for the
screening of therapeutically active molecules or for further
fundamental studies using genetically engineered cells.
MATERIALS AND METHODS
Recruitment and samples
Clinical data and pedigree information for the family reported in this
study were recorded by A. Me´garbane´ (Saint-Joseph University,
Beirut, Lebanon). Blood samples from each participating family
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Figure 6. Real-time quantitative reverse transcription-PCR (RT-PCR) analysis
and fibulin-5 detection in fibroblasts grown as monolayers. (a) Real-time
quantitative RT-PCR analysis of FBN1, LOX, LOXL, FBLN5, and ELN gene
expression in dermal fibroblasts. Total RNAs were extracted and reverse
transcribed after 2 days of post-confluence. Gene expression was normalized
to the expression of the reference GAPDH gene and expressed in relative
means±SEM. (b) Western blot analysis of fibulin-5 performed on cell
lysates and conditioned media after 24 hours of culture without serum.
GAPDH was immunodetected to check that equal amounts of protein
from lysates were loaded.
a b
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e f
Control SE CL-SE
Figure 7. Immunohistochemical analysis of SE dermal–epidermal junction
(DEJ). Control skin equivalents (a, c, e) and CL-SE (b, d, f) were harvested
after 42 days of fibroblast culture. Type-IV collagen (a, b), type-VII collagen
(c, d), and laminin (e, f) immunodetection was performed by
immunoperoxidase labeling. The immunolabeling is indicated by a brown
deposition and the counterstaining gives the tissue its blue color. The
chitosan-crosslinked collagen–GAG matrix appears in blue. Bar¼ 50mm,
insets 10mm.
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member and skin biopsies were collected after obtaining written
informed consent using standard procedures. The study was
approved by the Ethics Committee of the Hopital La Pitie-Salpetriere
(Paris, France), and all experiments were performed in accordance
with the Declaration of Helsinki Principles. DNA was extracted from
peripheral blood leukocytes, and cell lines for the genetic analysis
were established by transfection with the Epstein–Barr virus using
standard procedures. CL skin samples were obtained from tiny
biopsies on the arms of both CL children, however, under conditions
that did not permit RNA extraction or isolation of keratinocytes.
Genetic analysis
Mutation analysis was performed on the DNA samples from both
affected patients, both unaffected parents, and both unaffected
brothers. Intronic oligonucleotide primers flanking the exons
for amplification and sequencing of the FBLN5 gene were designed
using the Primer3 software (http://frodo.wi.mit.edu). The PCR
reaction was carried out on 50 ng of genomic DNA with Hot Master
Taq DNA polymerase (Eppendorf, Le Pecq, France). After linear
amplification of purified PCR products using BigDye terminator mix
(Applied Biosystems, Courtaboeuf, France), the products were again
purified and sequenced on an Applied Biosystems Sequencer 3700.
Forward or reverse strands from all patients and controls were
sequenced for the entire coding region and exon/intron boundaries.
The sequences were analyzed using the Phred Phrap Consed
software (http://www.phrap.org/phredphrapconsed.html).
Monolayer cultures
Subcultures of CL and control fibroblasts from foreskin of a
9-year-old child were grown in fibroblast medium containing
DMEM (Invitrogen, GIBCO, Cergy Pontoise, France) supplemented
as described (Duplan-Perrat et al., 2000). Cells were seeded to
confluence in six-well plates (2 105 cells per well) and grown for
2 days in DMEM with Glutamax-1 (Invitrogen, GIBCO) supplemen-
ted with 10% fetal calf serum (Sigma, Saint Quentin Fallavier,
France) before total RNA extraction. Or after 24 hours, cells were
rinsed with PBS three times and then the medium was replaced by
DMEM with Glutamax-1 alone for 24 hours before conditioned
media harvest and protein extraction.
Preparation of SE
The SE was prepared as reported previously (Duplan-Perrat et al.,
2000) using either control fibroblasts or fibroblasts from the CL
donor. In both cases, keratinocytes were derived from foreskin of
a 9-year-old child. Fibroblasts at passage 5 were seeded onto
a dermal substrate and grown for 14 or 21 days at 37 1C in a 5%
CO2 atmosphere in DMEM with Glutamax-1 (Invitrogen, GIBCO),
supplemented as described (Duplan-Perrat et al., 2000). The
medium was supplemented with 50 mgml1 L-ascorbic acid (Sigma)
and changed every day. Human foreskin keratinocytes were
prepared in a 3:1 mixture of DMEM and Ham’s F12 (Invitrogen,
GIBCO), respectively, supplemented as described (Duplan-Perrat
et al., 2000). Keratinocytes were seeded on the dermal equivalent on
day 14 or 21. After 7 days of submerged culture in the keratinocyte
medium, the SE was elevated to the air–liquid interface and cultured
in a simplified keratinocyte medium for 14 days. The SE samples
were harvested at 35 or 42 days of culture after fibroblast seeding.
A total of 15 SEs have been elaborated with the CL fibroblasts and
control fibroblasts. In CL and control conditions, five SEs were used
for IHC experiments, five SEs for transmission electron microscopy,
and five SEs were lysed for total RNA extraction and PCR.
Gene expression analyses by real-time quantitative reverse
transcription-PCR
Total RNA was extracted from SEs using the SV 96 Total RNA
Isolation System (Promega, Charbonnie`res, France) or from mono-
layer cultures with the RNeasy mini-kit (Qiagen, Courtaboeuf,
France). A total of 500 ng RNA was reverse transcribed using
RevertAid H-Minus First Strand cDNA Synthesis kit (Fermentas,
St Re´my Les Chevreuse, France). Real-time PCR was performed on a
cDNA mixture, equivalent to 40 ng of total RNA, with SYBR Green
Supermix (Bio-Rad, Marnes-La-Coquette, France). PCR amplifica-
tions were performed with 40 cycles of 15 seconds at 95 1C,
30 seconds at 59 1C, 30 seconds at 72 1C, and 15 seconds at 78 1C.
The primers were specific for glyceraldehyde dehydrogenase
(GAPDH): forward ACACCCACTCCTCCACCTTT, reverse AGCCAAA
TTCGTTGTCATACCAG; FBLN5: forward CGGCACATACTTCTG
CTCCTG, reverse GCTCACATTCGTTGATGTCTTGG; LOXL: forward
GCACCTCTCATACCCAGGGC, reverse TGGCAGTCGATGTCCGCAT;
FBN1: forward CTGCCCACCTGATTTTGAACTG, reverse CCAGAGC
GGGTATCAACACAG; ELN: forward GTTGGTGGCTTAGGAGTGT
CTG, reverse CGGCACTTTCCCAGGCTTC; LOX: forward CTCTGACG
ACAACCCTTATTACAAC, reverse CTGGGAGACCGTACTGGAAGT.
Semiquantitative PCR was performed using the comparative Ct method
as described (Cenizo et al., 2006). The real-time PCR experiments were
performed in triplicate on each SE and relative gene expressions were
normalized with reference to the GAPDH gene. Data are reported as
mean±SEM.
Western blotting
Fibulin-5 has been detected from cell extracts using RIPA lysis buffer
(50mM Tris-HCl pH 8.0, 150mM NaCl, 1% NP40, 0.5% sodium
deoxycholate, 0.1% SDS, 2mM EDTA, protease inhibitors from
Roche Diagnostics, Meylan, France), whereas proteins from condi-
tioned media were precipitated with 10% trichloroacetic acid and
washed with acetone. A total of 30mg proteins were separated by
10% SDS-polyacrylamide gels and transferred onto nitrocellulose
membranes. Even transfer was verified by Ponceau S staining.
Membranes were blocked for 45minutes at room temperature
with buffer containing 5% non-fatty milk in 0.1% T-PBS (Tween-
phosphate-buffered saline) (154mM NaCl, 1mM KH2PO4, 3mM
Na2HPO4, pH 7.4, 0.1% Tween-20). The blots were incubated at
room temperature for 1 hour with a polyclonal antibody raised
against human fibulin-5 (a generous gift from H. Yanagisawa, Dallas,
TX) or a monoclonal anti-GAPDH antibody (Chemicon MAB374;
Millipore, Billerica, MA) in 5% non-fatty milk in 0.1% T-PBS at a
dilution of 1:250 or 1:10,000, respectively. After washing the blots
with T-PBS, they were incubated with peroxidase-conjugated
anti-rabbit or anti-mouse IgG (Bio-Rad) for 1 hour and then washed
again with T-PBS and without Tween-20 before resolving using an
electrochemical luminescence kit (Chemicon).
Histological and immunohistological procedures
The surgical specimens and SEs were frozen or fixed in Bouin’s
fixative or in 10% formalin solution (Sigma) and were embedded in
paraffin. Sections (5mm) were de-paraffinized and whitened in
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glycine-HCl (100mmol l1) as described previously (Noblesse et al.,
2004). Beside the anti-LOX and anti-LOXL antibodies, the following
antibodies were used: anti-type-IV collagen (Novocastra, Newcastle
upon Tyne, UK), anti-laminin (Novocastra), anti-type-VII collagen
(Santa Cruz, Heidelberg, Germany), anti-elastin (Novotec, Lyon,
France), and anti-fibulin-5 (a generous gift from H. Yanagisawa,
Dallas, TX). The antibodies were used at the following dilution:
1:750 (anti-LOX222–356), 1:2,500 (anti-LOXL231–368), 1:200 (anti-
type-VII collagen, anti-elastin), 1:50 (anti-type-IV collagen, anti-
laminin, anti-fibulin-5). A peroxidase-conjugated goat anti-rabbit
and anti-mouse IgG kit (DAKO, Trappes, France) was used to
detect the immunocomplexes, using diaminobenzidine as substrate
(DAKO). Counterstaining was performed using Harris’s hematoxylin
(Sigma). Multiple serial sections of each specimen were processed to
ensure representative samples. For controls, the primary antibody
was omitted.
TUNEL assay
Apoptotic cells were stained using In Situ Cell Death Detection Kit,
TMR Red (Roche Diagnostics). Paraffin-embedded sections (5mm) of
SE were de-paraffinized using methylcyclohexane and rehydrated
through a graded series of ethanol and double-distilled water. Slides
were permeabilized for 8minutes at 25 1C in 0.1% Triton X-100,
0.1% citrate sodium and washed in PBS. For positive controls, 50 ml
of nuclease buffer (10mM Tris-HCl pH 7.5, 25mM CaCl2) containing
30Uml1 Micrococcal Nuclease (Fermentas) was applied to normal
SE for 10minutes at room temperature and rinsed in PBS three times.
Samples were then incubated for 1 hour at 37 1C in a humidified
chamber with the TUNEL reaction mixture consisting of TdT and
tetra-methyl-rhodamine-dUTP to directly label DNA strand breaks
with red fluorescence. Enzyme was omitted in negative controls.
To reduce the background absorption on chitosan fibres, the tetra-
methyl-rhodamine-dUTP solution was diluted 1:16 in TUNEL
dilution buffer (Roche Diagnostics). Slides were then washed in
PBS three times before fluorescence visualization with an Axioplan2
microscope (Zeiss, Le Pecq, France).
Transmission electron microscopy procedures. Samples were
fixed in 2% glutaraldehyde–0.1 M Na-cacodylate/HCl buffer at pH
7.4 for 1 hour at 4 1C and then post-fixed in 1% OsO4–0.15M
Na-cacodylate/HCl buffer at pH 7.4 for 1 hour at 4 1C, dehydrated in
graded ethanol, and embedded in Epon. Ultrathin sections were cut
with a RMX-MTL Ultramicrotome (VENTANA, Illkirch, France),
contrasted with methanolic uranyl acetate and lead citrate, and then
examined using a JEOL 1200 EX transmission electron microscope
equipped with MEGAVIEW II SIS numeric camera and AnalySIS
software.
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